Literature DB >> 33672223

The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.

Simon Grootendorst1, Jonathan de Wilde1, Birgit van Dooijeweert1, Annelies van Vuren2, Wouter van Solinge1, Roger Schutgens2, Richard van Wijk1, Marije Bartels2.   

Abstract

Rare hereditary anemias (RHA) represent a group of disorders characterized by either impaired production of erythrocytes or decreased survival (i.e., hemolysis). In RHA, the regulation of iron metabolism and erythropoiesis is often disturbed, leading to iron overload or worsening of chronic anemia due to unavailability of iron for erythropoiesis. Whereas iron overload generally is a well-recognized complication in patients requiring regular blood transfusions, it is also a significant problem in a large proportion of patients with RHA that are not transfusion dependent. This indicates that RHA share disease-specific defects in erythroid development that are linked to intrinsic defects in iron metabolism. In this review, we discuss the key regulators involved in the interplay between iron and erythropoiesis and their importance in the spectrum of RHA.

Entities:  

Keywords:  erythropoiesis; ineffective erythropoiesis; iron metabolism; iron overload

Mesh:

Substances:

Year:  2021        PMID: 33672223      PMCID: PMC7927117          DOI: 10.3390/ijms22042204

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  134 in total

1.  Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation.

Authors:  Junya Kanda; Chisaki Mizumoto; Hiroshi Kawabata; Hideyuki Tsuchida; Naohisa Tomosugi; Keitaro Matsuo; Takashi Uchiyama
Journal:  Haematologica       Date:  2008-07-18       Impact factor: 9.941

Review 2.  Haemochromatosis.

Authors:  Pierre Brissot; Antonello Pietrangelo; Paul C Adams; Barbara de Graaff; Christine E McLaren; Olivier Loréal
Journal:  Nat Rev Dis Primers       Date:  2018-04-05       Impact factor: 52.329

Review 3.  Diverse effects of platelet-derived growth factor-BB on cell signaling pathways.

Authors:  Chenbing Wang; Yanbo Liu; Dongning He
Journal:  Cytokine       Date:  2018-10-24       Impact factor: 3.861

Review 4.  How we manage patients with pyruvate kinase deficiency.

Authors:  Rachael F Grace; D Mark Layton; Wilma Barcellini
Journal:  Br J Haematol       Date:  2019-01-25       Impact factor: 6.998

5.  Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.

Authors:  Kleber Yotsumoto Fertrin; Carolina Lanaro; Carla Fernanda Franco-Penteado; Dulcinéia Martins de Albuquerque; Mariana Rezende Bandeira de Mello; Flávia Rubia Pallis; Marcos André Cavalcanti Bezerra; Betania Lucena Domingues Hatzlhofer; Gordana Olbina; Sara Terezinha Olalla Saad; Aderson da Silva Araújo; Mark Westerman; Fernando Ferreira Costa
Journal:  Am J Hematol       Date:  2014-04       Impact factor: 10.047

6.  Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis.

Authors:  Ryan Zarychanski; Vincent P Schulz; Brett L Houston; Yelena Maksimova; Donald S Houston; Brian Smith; Jesse Rinehart; Patrick G Gallagher
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

Review 7.  Epidemiology of rare anaemias in Europe.

Authors:  Beatrice Gulbis; Androulla Eleftheriou; Michael Angastiniotis; Sarah Ball; Jordi Surrallés; María Castella; Hermann Heimpel; Anita Hill; Joan-Lluis Vives Corrons
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

9.  Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II.

Authors:  Roberta Russo; Immacolata Andolfo; Francesco Manna; Gianluca De Rosa; Luigia De Falco; Antonella Gambale; Mariasole Bruno; Alessandro Mattè; Paolo Ricchi; Domenico Girelli; Lucia De Franceschi; Achille Iolascon
Journal:  Blood       Date:  2016-08-18       Impact factor: 22.113

10.  Identification of erythroferrone as an erythroid regulator of iron metabolism.

Authors:  Léon Kautz; Grace Jung; Erika V Valore; Stefano Rivella; Elizabeta Nemeth; Tomas Ganz
Journal:  Nat Genet       Date:  2014-06-01       Impact factor: 38.330

View more
  1 in total

Review 1.  Molecular Pathways Involved in the Development of Congenital Erythrocytosis.

Authors:  Jana Tomc; Nataša Debeljak
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.